Skip to main content

Table 3 Model economic parameters: base case

From: Economic impact of improving patient safety using Sugammadex for routine reversal of neuromuscular blockade in Spain

Pharmacological costs

Agent

Dose

Drug Cost

Source

Sugammadex (moderate block)a

2 mg

€51.34

BotPlus

Sugammadex (deep block)a

4 mg

€102.68

BotPlus

Neostigmine/Atropine

0.5 mg/2 mg

€0.46

BotPlus

Rocuronium

0.6 mg

€1.80

BotPlus

Post-operative event

Cost

Source

Atelectasis

€4999.40

DRG cost. MoH

Pneumonia

€4449.72

eSalud. Oblikue

  1. aAn average patient weight of 75 kg was assumed in estimating the cost per dose, with vial wastage of any unused amount